AllSci’s technology transforms how pharmaceutical and biotech companies understand the R&D landscape, improves their research productivity, and helps them differentiate their portfolios and strategy
AllSci Launches AI Development Partner Program to Accelerate Pharmaceutical and Biotechnology R&D
Exclusive Early Access to AllSci’s Groundbreaking Scientific AI Platform
NORTH BETHESDA, Md., Jan. 23, 2025 /PRNewswire/ — AllSci has opened its Development Partner Programto R&D-driven life science organizations seeking to leverage the power of its revolutionary AI platform. This exclusive program offers early access to AllSci’s proprietary pharmaceutical hypothesis database, advanced visualization engine, and AERIS—AllSci’s cutting-edge AI purpose-built for research and scientific knowledge discovery.
Program partners will collaborate closely with AllSci to derive data-driven insights that inform their portfolio strategies, uncover R&D opportunities and gaps, and empower their researchers with tools to improve their efficiency, knowledge, and workflows.
Why Partner with AllSci?
AllSci’s proprietary AERIS AI extracts research hypotheses, gathers supporting and refuting evidence from the literature, and visualizes the evolution and context of related science over time.
By joining the Development Partner Program, pharmaceutical and biotechnology organizations gain exclusive entry to AERIS and other transformative R&D tools.
- Access Hypotheses: Explore science through supported and refuted hypotheses in addition to traditional articles and abstracts.
- Identify Gaps and Opportunities: Map the scientific landscape through embedding visualizations that highlight research gaps and opportunities.
- Benchmark: Analyze the research ecosystem, including concepts, organizations, and individual contributors.
- Find Collaborators: Map collaboration networks and connect with the right potential partners.
- Optimize Portfolio: Gain insights into molecules and technologies within the R&D pipeline.
A Game-Changer for Pharma and Biotech
“AllSci’s technology transforms how pharmaceutical and biotech companies understand the R&D landscape, improves their research productivity, and helps them differentiate their portfolios and strategy” said Matthew Chervenak, Founder and CEO of AllSci.
Secure Your Spot
Pharmaceutical and biotechnology organizations are invited to explore this opportunity to redefine their approach to research. Participation in the Development Partner Program is limited.
For more information and to apply, please email us at [email protected].